Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C29H29N3O3S |
Molecular Weight | 499.624 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(CC1=CC=C(OC2=NC=CC=C2C#N)C=C1)NC[C@H](O)COC3=CC=CC=C3C4=CC=CS4
InChI
InChIKey=WIKLBKJBYSBYLL-QHCPKHFHSA-N
InChI=1S/C29H29N3O3S/c1-29(2,17-21-11-13-24(14-12-21)35-28-22(18-30)7-5-15-31-28)32-19-23(33)20-34-26-9-4-3-8-25(26)27-10-6-16-36-27/h3-16,23,32-33H,17,19-20H2,1-2H3/t23-/m0/s1
Molecular Formula | C29H29N3O3S |
Molecular Weight | 499.624 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Lubabegron was initially studied in the Eli Lilly’s lab for potential applications in human health. The drug is a beta-adrenergic agonist that has the effect of increasing the breakdown of fats and increasing energy expenditure in cells. Lubabegron is the first animal drug that was approved to reduce ammonia gas emissions from an animal or its waste. These ammonia gasses can come from many sources and can affect the health of people, animals and the environment.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:42:45 GMT 2023
by
admin
on
Sat Dec 16 05:42:45 GMT 2023
|
Record UNII |
8501207BZX
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID20192436
Created by
admin on Sat Dec 16 05:42:45 GMT 2023 , Edited by admin on Sat Dec 16 05:42:45 GMT 2023
|
PRIMARY | |||
|
8501207BZX
Created by
admin on Sat Dec 16 05:42:45 GMT 2023 , Edited by admin on Sat Dec 16 05:42:45 GMT 2023
|
PRIMARY | |||
|
ZZ-87
Created by
admin on Sat Dec 16 05:42:45 GMT 2023 , Edited by admin on Sat Dec 16 05:42:45 GMT 2023
|
PRIMARY | |||
|
C175118
Created by
admin on Sat Dec 16 05:42:45 GMT 2023 , Edited by admin on Sat Dec 16 05:42:45 GMT 2023
|
PRIMARY | |||
|
8501207BZX
Created by
admin on Sat Dec 16 05:42:45 GMT 2023 , Edited by admin on Sat Dec 16 05:42:45 GMT 2023
|
PRIMARY | |||
|
9752
Created by
admin on Sat Dec 16 05:42:45 GMT 2023 , Edited by admin on Sat Dec 16 05:42:45 GMT 2023
|
PRIMARY | |||
|
2360331
Created by
admin on Sat Dec 16 05:42:45 GMT 2023 , Edited by admin on Sat Dec 16 05:42:45 GMT 2023
|
PRIMARY | |||
|
391920-32-4
Created by
admin on Sat Dec 16 05:42:45 GMT 2023 , Edited by admin on Sat Dec 16 05:42:45 GMT 2023
|
PRIMARY | |||
|
60085980
Created by
admin on Sat Dec 16 05:42:45 GMT 2023 , Edited by admin on Sat Dec 16 05:42:45 GMT 2023
|
PRIMARY | |||
|
300000034339
Created by
admin on Sat Dec 16 05:42:45 GMT 2023 , Edited by admin on Sat Dec 16 05:42:45 GMT 2023
|
PRIMARY | |||
|
CHEMBL2364615
Created by
admin on Sat Dec 16 05:42:45 GMT 2023 , Edited by admin on Sat Dec 16 05:42:45 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|